SEC Form 4 · accession 0000899243-15-002335
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia R Brown
Director
Period of report
Aug 4, 2015
Accepted (ET)
Aug 5, 2015 · 11:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $2.35 | Aug 4, 2015 | A | 12,500 | A | Aug 4, 2015 | Aug 4, 2025 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1The Stock Option vests and becomes exercisable in full as of the date of grant.
- F2The Stock Option expires on August 4, 2025; provided, however, that in the event of the director's termination of service as a member of the board, the Stock Option will expire upon the first to occur of the close of the period of three years next succeeding the termination date or the expiration of the option term.